Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
11.59
+0.24 (2.11%)
At close: Apr 28, 2026, 4:00 PM EDT
11.69
+0.10 (0.86%)
After-hours: Apr 28, 2026, 4:52 PM EDT
Immatics Market Cap
Immatics has a market cap or net worth of $1.55 billion as of April 28, 2026. Its market cap has increased by 222.07% in one year.
Market Cap
1.55B
Enterprise Value
1.02B
1-Year Change
222.07%
Ranking
Category
Stock Price
$11.59
Market Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $1.55B, an increase of 800.97%. That is a compound annual growth rate of 34.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.52B | 8.12% |
| Dec 31, 2025 | 1.41B | 65.88% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rapport Therapeutics | 1.62B |
| Intellia Therapeutics | 1.62B |
| Nanobiotix | 1.61B |
| Generate Biomedicines | 1.60B |
| Oculis Holding AG | 1.60B |
| Nuvation Bio | 1.57B |
| AtaiBeckley | 1.57B |
| Damora Therapeutics | 1.52B |